Product nameAnti-Elafin/ESI antibody
See all Elafin/ESI primary antibodies
DescriptionRabbit polyclonal to Elafin/ESI
Tested applicationsSuitable for: WB, IHC-Pmore details
Species reactivityReacts with: Mouse, Human
Recombinant fragment within Human Elafin/ESI (internal sequence). The exact sequence is proprietary.
Database link: P19957
- IHC-P: Mouse muscle tissue. WB: HEK-293T cell.
Storage instructionsShipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C long term. Avoid freeze / thaw cycle.
Storage bufferpH: 7.00
Preservative: 0.025% Proclin 300
Constituents: PBS, 20% Glycerol
Concentration information loading...
PurityImmunogen affinity purified
Our Abpromise guarantee covers the use of ab272906 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|WB||1/500 - 1/3000.|
|IHC-P||1/100 - 1/1000.|
FunctionNeutrophil and pancreatic elastase-specific inhibitor of skin. It may prevent elastase-mediated tissue proteolysis.
Sequence similaritiesContains 1 WAP domain.
DomainConsists of two domains: the transglutaminase substrate domain (cementoin moiety) and the elastase inhibitor domain. The transglutaminase substrate domain serves as an anchor to localize elafin covalently to specific sites on extracellular matrix proteins.
- Information by UniProt
- Cementoin antibody
- ELAF_HUMAN antibody
- Elafin antibody
Paraffin embedded mouse muscle tissue stained for Elafin using ab272906 at 1/500 dilution in immunohistochemical analysis. Antigen retrieval using EDTA based, pH 8.0 buffer, 15 minutes.
All lanes : Anti-Elafin/ESI antibody (ab272906) at 1/1000 dilution
Lane 1 : HEK-293T whole cell lysate
Lane 2 : PI3 transfected HEK-293T whole cell lysate
Lysates/proteins at 30 µg per lane.
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
ab272906 has not yet been referenced specifically in any publications.